The Centers for Medicare and Medicaid Services has confirmed the standard monthly premium will rise to $202.90 next year.

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The measure lowers prescription drug costs for seniors by empowering Medicare to negotiate the cost of prescription drugs. The negotiated prices include:

The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in net covered prescription costs.

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations

AdvaMed supports the legislation, which is intended to ensure AI-enabled devices receive an accurate CMS payment code.

A higher Medicare Part B premium in 2026 could erode next year's cost-of-living adjustment for Social Security recipients, experts say.

The 9.7% increase in the cost of Medicare Part B premiums for 2026 is due to several factors, including projected growth in Medicare Advantage and outpatient care next year